Adolescent Premature Ovarian Insufficiency Following Human Papillomavirus Vaccination: A Case Series Seen in General Practice.

This may be significant since injected substances in both placebo control arms have either a suggested association with autoimmune ovarian damage 17 or known direct ovarian toxicity. 47 Completed vaccine and placebo courses each administered 675 μg of aluminum to older girl safety study participants; or components including 150 μg polysorbate 80 to all 9- to 15-year-old safety study participants.

also in 13,097 other papers